title: Disruptive technology: new medical advances are troublesome for even the most successful health systems and innovator health companies.
abstract: An independent expert panel conducted a multi-year research/education/advocacy initiative on the impact of the new drug-eluting stent technology. They conclude that this technology represents a "tipping point" in a series of transformative drugs and medical devices, often used in combination, and recommend that healthcare decision makers develop careful, data-based strategies to avoid the disruptiveness of these medical advances.
authors.affiliation: Northwestern Memorial Hospital, Chicago, IL, USA.
authors.forename: Lawrence
authors.initials: L
authors.lastname: Michaelis
authors.forename: Joanne
authors.initials: J
authors.lastname: Vaul
authors.forename: Kathleen
authors.initials: K
authors.lastname: Chumer
authors.forename: Maureen
authors.initials: M
authors.lastname: Faul
authors.forename: Lisa
authors.initials: L
authors.lastname: Sheehan
authors.forename: Jack
authors.initials: J
authors.lastname: DeCerce
mesh_terms: D003659:Decision Making, Organizational; D003695:Delivery of Health Care / Q000458:organization & administration; D004059:Diffusion of Innovation; D016503:Drug Delivery Systems; D004864:Equipment and Supplies / Q000009:adverse effects*; D015607:Stents; D014481:United States